Nyxoah SA
IPO| Nyxoah
Public · Mont-Saint-Guibert, Belgium · Founded 2009 · $58.8M raised
- Headquarters
- Mont-Saint-Guibert
- Employees
- 51–200
- Founded
- 2009
- Business Model
- B2B
- Website
- nyxoah.com
- Total Funding
- $58.8M
- Last Round
- $28.0M Series CFeb 2020
- Rounds
- 3
- Type
- Public
About
Medical device company developing the Genio leadless hypoglossal neurostimulation system for obstructive sleep apnea treatment.
Summary
Nyxoah SA is a Healthcare company based in Mont-Saint-Guibert, Belgium, founded in 2009. It has raised $58.8M in total across 3 rounds, most recently a $28.0M Series C round in Feb 2020. Investors include European Investment Bank, ResMed and Cochlear Limited.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe